IFNA1 and COVID-19: First, kinetic analyses in mild/asymptomatic COVID-19 patients demonstrated an elevated frequency of pDC IFN-α+ levels in absence of stimulation that vanished over time while, relatively, their ability to respond to SARS-CoV-2-infected cells increased at late time-points (Fig. 2h, left panel).